Abstract-Endothelin-1 (ET-1), a potent vasoconstrictor, has been implicated in the pathogenesis of coronary vasospasm by enhancing coronary vasoconstriction to vasoactive eicosanoids; however, the cellular mechanisms involved are unclear. We investigated whether physiological concentrations of ET-1 enhance coronary smooth muscle contraction to vasoactive eicosanoids by activating specific protein kinase C (PKC) isoforms. Cell contraction was measured in single smooth muscle cells isolated from porcine coronary arteries, intracellular free Ca 2ϩ ([Ca 2ϩ ] i ) was measured in fura-2-loaded cells, and the cytosolic and particulate fractions were examined for PKC activity and reactivity with isoform-specific anti-PKC antibodies using Western blots. In Hanks -7 mol/L) caused cell contraction (10%) and enhanced PGF 2␣ contraction (33%) with no additional increase in [Ca 2ϩ ] i (115Ϯ7 nmol/L). The ET-1-induced enhancement of PGF 2␣ contraction was inhibited by Gö6976 (10 -6 mol/L), an inhibitor of Ca 2ϩ -dependent PKC isoforms. Both ET-1 and PDBu caused an increase in PKC activity in the particulate fraction and a decrease in the cytosolic fraction and increased the particulate/cytosolic PKC activity ratio. Western blots revealed the Ca 2ϩ -dependent ␣-PKC and the Ca 2ϩ -independent ␦-, ⑀-, and -PKC isoforms. In resting tissues, ␣-and ⑀-PKC were mainly cytosolic, ␦-PKC was mainly in the particulate fraction, and -PKC was equally distributed in the cytosolic and particulate fraction. ET-1 (10 pmol/L) alone or PDBu (10 -7 mol/L) alone caused translocation of ⑀-PKC from the cytosolic to the particulate fraction, localized ␦-PKC more in the particulate fraction, but did not change the distribution of -PKC. PGF 2␣ (10 -7 mol/L) alone did not change PKC activity. In tissues pretreated with ET-1 or PDBu, PGF 2␣ caused additional increases in ␣-PKC activity. Thus, the enhancement of PGF 2␣ -induced coronary smooth muscle contraction by physiological concentrations of ET-1 involves activation and translocation of ␣-PKC in addition to ␦-and ⑀-PKC isoforms, and this may represent one possible cellular mechanism by which ET-1 could enhance coronary vasoconstriction to vasoactive eicosanoids in coronary vasospasm.